Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radpharm Scientific is a prominent Australian manufacturer and distributor of radiopharmaceuticals and nuclear medicine products. Based in Canberra, the company operates a specialized TGA-licensed facility that produces a wide range of diagnostic imaging agents and therapeutic isotopes. Their core portfolio includes Technetium-99m generators and various cold kits used for bone, renal, and lung imaging, as well as therapeutic Iodine-131 for thyroid conditions. Since its acquisition by Global Medical Solutions in 2011, Radpharm has served as a critical hub for nuclear medicine supply in the Asia-Pacific region. The company provides essential services to hospitals and clinics, maintaining high standards of GMP compliance in the production of radioactive medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radpharm Scientific.